Moola Joghee Nanjan Chandrasekar (Chandrasekar Mjn)

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Sunil Kumar Patnaik, Akey Krishna Swaroop, Mudavath Ravi Naik, Jubie Selvaraj, Moola Joghee Nanjan Chandrasekar
Repurposing of FDA Approved Drugs and Neuropep peptides as Anticancer Agents Against ErbB1 and ErbB2. Drug research (2023)
Sunil Kumar Patnaik, Selvaraj Ayyamperumal, Dhananjay Jade, Nagarjuna Palathoti, Krishna Swaroop Akey, Srikanth Jupudi, Michael A Harrison, Sreenivasan Ponnambalam, Nanjan Mj, Moola Joghee Nanjan Chandrasekar
Virtual high throughput screening of natural peptides against ErbB1 and ErbB2 to identify potential inhibitors for cancer chemotherapy. Journal of biomolecular structure & dynamics (2023)

Moola Joghee Nanjan Chandrasekar.css-eqlu8i{font-size:small;padding-left:4px;} (Chandrasekar Mjn)